# Ubiquinol (Reduced COQ10) for Patients With Sepsis

> **NCT01948063** · PHASE2 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 38 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Ubiquinol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01948063
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948063, "Ubiquinol (Reduced COQ10) for Patients With Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01948063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*